KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Cash from Investing Activities: 2009-2025

Historic Cash from Investing Activities for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to -$33.7 million.

  • Charles River Laboratories International's Cash from Investing Activities fell 58.02% to -$33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$192.6 million, marking a year-over-year increase of 52.71%. This contributed to the annual value of -$245.1 million for FY2024, which is 56.48% up from last year.
  • Latest data reveals that Charles River Laboratories International reported Cash from Investing Activities of -$33.7 million as of Q3 2025, which was up 9.76% from -$37.3 million recorded in Q2 2025.
  • Charles River Laboratories International's Cash from Investing Activities' 5-year high stood at $44.4 million during Q4 2022, with a 5-year trough of -$954.2 million in Q2 2021.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$76.1 million (2024), whereas its average is -$84.1 million.
  • Per our database at Business Quant, Charles River Laboratories International's Cash from Investing Activities tumbled by 3,233.31% in 2021 and then soared by 376.88% in 2022.
  • Charles River Laboratories International's Cash from Investing Activities (Quarterly) stood at $9.3 million in 2021, then soared by 376.88% to $44.4 million in 2022, then plummeted by 637.08% to -$238.4 million in 2023, then skyrocketed by 68.07% to -$76.1 million in 2024, then tumbled by 58.02% to -$33.7 million in 2025.
  • Its Cash from Investing Activities stands at -$33.7 million for Q3 2025, versus -$37.3 million for Q2 2025 and -$45.5 million for Q1 2025.